Clinical Trial Update: The Dallas Hereditary Spherocytosis Cohort Study

View source ↗

Summary

The Dallas Hereditary Spherocytosis Cohort Study (NCT01141621) sponsored by University of Texas Southwestern Medical Center has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Spherocytosis

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hereditary Spherocytosis | Status: TERMINATED